Skip to main content
. 2023 Sep 30;12(19):e024034. doi: 10.1161/JAHA.121.024034

Figure 2. Risk of developing severe Fontan‐associated liver disease (FALD)/severe liver complications (SLCs) in matched Fontan vs ventricular septal defect (VSD) cohorts.

Figure 2

Ten‐year cumulative risk of developing severe FALD/SLCs in patients who undergo the Fontan procedure (Fontan patients) is 11.95%; and in patients with VSD, it is 0.50%. Long‐term (35‐year) cumulative risk of developing severe FALD/SLCs in Fontan patients is 52.24%; and in patients with VSD, it is 2.75%. Log‐rank P<0.0001. FU indicates follow‐up.